Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ACB · against 391 other Healthcare companies of similar size
Ranked #194 of 392 · scores higher than 51% of peers · safety percentile 59
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)30 peers with a safety percentile of 50–59, including ACB · Click a bar to see the companies
A mix: stronger debt / equity and current ratio, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ACB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 360 reported | 0.04× | 0.19× | 72% | 33% | |
| BetaLower is better · 376 reported | 1.42 | 0.45 | 11% | 33% | |
| Current ratioHigher is better · 386 reported | 5.36× | 2.97× | 69% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 421M USD | 99 | 52 | |
| 3 | 165M USD | 99 | 50 | |
| 4 | 261M USD | 99 | 97 | |
| 5 | 397M USD | 99 | 37 | |
| 190 | 2.1B CNY (≈$290M) | 60 | 27 | |
| 191 | 3.1B CNY (≈$439M) | 60 | 25 | |
| 192 | 2.91T IDR (≈$180M) | 59 | 50 | |
| 193 | 2.1B CNY (≈$295M) | 59 | 39 | |
| 194 | 327M USD | 59 | 40 | |
| 195 | 302M USD | 59 | 42 | |
| 196 | 37.3B JPY (≈$254M) | 58 | 66 | |
| 197 | 4.4B CNY (≈$613M) | 58 | 60 | |
| 198 | 4.5B CNY (≈$633M) | 57 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score